Neo-Adjuvant FOLFOX for Rectal Carcinoma

ClinicalTrials.gov ID: NCT00832299

Public ClinicalTrials.gov record NCT00832299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Open- Labeled, Prospective Study to Determine the Efficacy of Pre- Operative Chemotherapy With Six Cycles of Modified FOLFOX 6 Followed by Total Mesorectal Excision (TME) Followed by an Additional Six Cycles of FOLFOX 6

Study identification

NCT ID: NCT00832299
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: Beth Israel Medical Center; Other
Enrollment: 2 participants

Conditions and interventions

Conditions

Rectal Neoplasms

Interventions

FOLFOX Drug
total mesorectal excision (TME) Procedure

Drug · Procedure

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2008
Primary completion: Jul 31, 2011
Completion: Jul 31, 2011
Last update posted: Feb 28, 2018

2009 – 2011

United States locations

U.S. sites: 2
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Beth Israel Medical Center	New York	New York	10003	—
St. Luke's Roosevelt Hospital Center	New York	New York	10019	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00832299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 28, 2018 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00832299 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →